@placeboed you have to use the chemotherapy regime for the patients recruited. FOLFIRINOX is a very toxic chemotherapy, its a cocktail of 4 chemotherapies blended and is only used for the patients that are the healthiest, a small percentage of pancreatic patients so the Overall Survival data for this subset is higher.
Most pancreatic cancer patients in Australia and US are now using Gemcitabine + Abraxane. Abraxane is chemotherapy with solvent that is less toxic of nano particles of human serum albium.
Use of Abraxane shows a 8 month OS, a 6 week OS median advantage over Gemcitabine alone.
https://www.ncbi.nlm.nih.gov/pubmed/29950811
16 months OS for Gemcitabine + Abraxane + OncoSil is big news for the oncology community.
- Forums
- ASX - By Stock
- Ann: Positive Overall Survival data released at ASCO 2019 Chicago
OSL
oncosil medical ltd
Add to My Watchlist
8.33%
!
$1.11

@placeboed you have to use the chemotherapy regime for the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.11 |
Change
0.085(8.33%) |
Mkt cap ! $15.50M |
Open | High | Low | Value | Volume |
$1.05 | $1.12 | $1.03 | $32.1K | 30.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16106 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 1980 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16106 | 1.090 |
1 | 7500 | 1.080 |
1 | 15000 | 1.050 |
1 | 2500 | 1.030 |
1 | 10000 | 1.025 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 1980 | 2 |
1.170 | 835 | 1 |
1.180 | 6234 | 1 |
1.200 | 65603 | 3 |
1.230 | 45403 | 2 |
Last trade - 11.05am 26/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online